首页 | 本学科首页   官方微博 | 高级检索  
     


Complement activation product C4d in oral and oropharyngeal squamous cell carcinoma
Authors:D Ajona  MJ Pajares  MD Chiara  JP Rodrigo  E Jantus‐Lewintre  C Camps  C Suarez  JV Bagán  LM Montuenga  R Pio
Affiliation:1. Program in Solid Tumors and Biomarkers, Center for Applied Medical Research (CIMA), Pamplona, Spain;2. Navarra's Health Research Institute (IDISNA), Pamplona, Spain;3. Department of Histology and Pathology, School of Medicine, University of Navarra, Pamplona, Spain;4. Servicio de Otorrinolaringología, Hospital Universitario Central de Asturias, Instituto Universitario de Oncología del Principado de Asturias, Universidad de Oviedo, Oviedo, Spain;5. Molecular Oncology Laboratory, Fundación para la Investigación del Hospital General Universitario de Valencia, Valencia, Spain;6. Department of Biotechnology, Universitat Politècnica de Valencia, Valencia, Spain;7. Department of Medicine, University of Valencia, Valencia, Spain;8. Department of Medical Oncology, Hospital General Universitario de Valencia, Valencia, Spain;9. Department of Oral Medicine, University of Valencia, and Service of Stomatology and Maxillofacial Surgery, University General Hospital, Valencia, Spain;10. Department of Biochemistry and Genetics, School of Sciences, University of Navarra, Pamplona, Spain
Abstract:
Keywords:head and neck cancer  squamous cell carcinoma  oral cancer  biomarker  diagnosis  complement system  C4d  saliva
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号